Your browser doesn't support javascript.
loading
Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.
Bennani, N Nora; Tun, Aung M; Carson, Kenneth R; Geiger, Jessica L; Maeda, Lauren S; Savage, Kerry J; Rose, Jim; Pinter-Brown, Lauren; Lunning, Matthew A; Abramson, Jeremy S; Bartlett, Nancy L; Vose, Julie M; Evens, Andrew M; Smith, Sonali M; Horwitz, Steven M; Ansell, Stephen M; Advani, Ranjana H.
Affiliation
  • Bennani NN; Division of Hematology, Mayo Clinic, Rochester, MN. Electronic address: bennani.nora@mayo.edu.
  • Tun AM; Division of Hematology, Mayo Clinic, Rochester, MN; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Cancer Center, Kansas City, KS.
  • Carson KR; Research Service, St Louis Veterans Affairs Medical Center, St. Louis, MO; Division of Oncology, Washington University School of Medicine, St. Louis, MO.
  • Geiger JL; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Maeda LS; Division of Oncology, Stanford Cancer Institute, CA.
  • Savage KJ; Centre for Lymphoid Cancer and Department of Medical Oncology, BC Cancer, Vancouver, BC.
  • Rose J; Centre for Lymphoid Cancer and Department of Medical Oncology, BC Cancer, Vancouver, BC.
  • Pinter-Brown L; Divisions of Hematology/Oncology, UCLA, Los Angeles, CA.
  • Lunning MA; Divisions of Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE.
  • Abramson JS; Divisions of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Boston, MA.
  • Bartlett NL; Division of Oncology, Washington University School of Medicine, St. Louis, MO.
  • Vose JM; Divisions of Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE.
  • Evens AM; U Mass Memorial Cancer Center, Worcester, MA.
  • Smith SM; Divisions of Hematology/Oncology, University of Chicago, Chicago, IL.
  • Horwitz SM; Division of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY.
  • Ansell SM; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Advani RH; Division of Oncology, Stanford Cancer Institute, CA.
Clin Lymphoma Myeloma Leuk ; 22(5): e300-e309, 2022 05.
Article in En | MEDLINE | ID: mdl-34848181
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Extranodal NK-T-Cell Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Lymphoma Myeloma Leuk Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Extranodal NK-T-Cell Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Lymphoma Myeloma Leuk Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication: United States